Elsevier

Human Pathology

Volume 20, Issue 3, March 1989, Pages 269-272
Human Pathology

Original contribution
Primary mucosal malignant melanoma: An immunohistochemical study of 12 cases with comparison to cutaneous and metastatic melanomas

https://doi.org/10.1016/0046-8177(89)90135-4Get rights and content

Abstract

Immunohistochemical analysis of 40 formalin-fixed, paraffin-embedded malignant melanomas (12 primary mucosal, 16 primary cutaneous, and 12 metastatic cutaneous) was performed to study the possible differences in immunostaining profiles according to location. The majority of melanomas were reactive with a polyclonal antibody to S100 protein (P-S100; 85%), a monoclonal melanoma-specific antibody (HMB-45; 88%), and a monoclonal antibody to vimentin (90%), and there were no differences in staining profiles for these antibodies by anatomic location. In contrast, while 13 of 16 cutaneous melanomas (81%) and ten of 12 metastatic melanomas (83%) were reactive with a monoclonal antibody to S100 protein (MoAb-079), only five of 12 mucosal tumors (42%) showed positive staining for MoAb-079. Similarly, 14 cutaneous melanomas (88%) and 11 metastatic melanomas (92%) showed positive staining for neuron specific enolase (NSE), while only four mucosal melanomas (33%) were NSE-positive. Of the 40 melanomas, all but two were reactive with either P-S100, MoAb-079, or HMB-45. These findings suggest that MoAb-079 and NSE may be less sensitive markers than P-S100 and HMB-45 for routinely processed mucosal melanomas as compared with cutaneous and metastatic tumors.

References (25)

  • RM Esclamado et al.

    Unique proteins defined by monoclonal antibodies specific for human melanoma. Some potential clinical applications

    Am J Surg

    (1986)
  • RA Erlandson

    Diagnostic immunohistochemistry of human tumors: An interim evaluation

    Am J Surg Pathol

    (1984)
  • GA Herrera et al.

    S-100 protein expression by primary and metastatic adenocarcinomas

    Am J Clin Pathol

    (1988)
  • HJ Kahn et al.

    Role of antibody to S-100 protein in diagnostic pathology

    Am J Clin Pathol

    (1983)
  • T Nakajima et al.

    An immunoperoxidase study of S-100 protein distribution in normal and neoplastic tissues

    Am J Surg Pathol

    (1982)
  • AJ Cochran et al.

    Detection of S-100 protein as an aid to the identification of melanocytic tumors

    Int J Cancer

    (1982)
  • RA DeLellis et al.

    The role of immunohistochemistry in the diagnosis of poorly differentiated malignant neoplasms

    Semin Oncol

    (1987)
  • KC Gatter et al.

    An immunocytochemical study of malignant melanoma and its differential diagnosis from other malignant tumours

    J Clin Pathol

    (1985)
  • AM Gown et al.

    Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes

    Am J Pathol

    (1986)
  • H Hachisuka et al.

    Immunohistochemical study of S-100 protein and neuron specific enolase (NSE) in melanocytes and the related tumors

    Acta Histochem

    (1986)
  • G Jundt et al.

    S-100 protein in amelanotic melanomas. A convenient immunocytochemical approach compared to electron microscopy

    Pathol Res Pract

    (1986)
  • LG Kindblom et al.

    S-100 protein in melanocytic tumors. An immunohistochemical investigation of benign and malignant melanocytic tumors and metastases of malignant melanoma and a characterization of the antigen in comparison to human brain

    Acta Pathol Microbiol Immunol Scand [A]

    (1984)
  • Cited by (27)

    • Pathology of Melanoma

      2020, Surgical Clinics of North America
      Citation Excerpt :

      A high rate of amelanotic lesions also pose a diagnostic challenge. Tumor markers, however, such as S-100, tyrosinase, HMB-45, and MART-1, confirm melanocytic origin.72 Genetically, PMMs show a higher frequency of KIT mutations.73

    • Malignant melanoma of the lip spreading in a pagetoid manner into the minor salivary glands

      2002, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics
      Citation Excerpt :

      Other antibodies such as MART-1 and anti-S-100 could be used as well. A notice of caution is in place: some monoclonal antibodies to S-100 do not react with oral melanomas.11 This case report, coupled with our extensive review of the literature, suggests that pagetoid extension of oral or labial melanoma along the ducts of salivary glands is a rare form of melanoma spread.

    • Posttraumatic spindle cell nodule of the buccal mucosa. Report of a case

      1992, Oral Surgery, Oral Medicine, Oral Pathology
    View all citing articles on Scopus

    Presented in part at the 77th Annual Meeting of the US-Canadian Academy of Pathology, Washington, DC, March 1988.

    View full text